PRIMEBODY Trademark

Pharmaceutical preparations for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; therapeutic pharmaceuticals for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; pharmaceutical preparations, namely, a pro-drug being a drug delivery system comprising biologics in the form of masked antibody and protein compounds for intravenous administration that facilitate conditional activation release of tissue and tumor targeting pharmaceuticals; diagnostic agents, preparations, and substances for medical purposes; therapeutic agents, preparations, and substances for medical purposes, namely, masked antibodies and proteins in the form of therapeutic biological preparations for use in the treatment of cancer, immune-related disorders, autoimmune diseases, metabolic and cardiometabolic disorders; pharmaceutical preparations and substances for the treatment of cancer, immune-related disorders, autoimmune diseases, metabolic and cardiometabolic disorders, and inflammatory conditions in the field of oncology, immunology, autoimmune, metabolic, and inflammatory diseases; diagnostic agents and preparations in the nature of biochemical reagents for medical purposes

Scientific and technological services, namely, research and development in the fields of pharmaceuticals, biotechnology, and medical diagnostics namely, preparations, biologics, and diagnostic agents; development of pharmaceutical drugs for oncology, immunology, autoimmune, metabolic, and inflammatory diseases, conditionally-activated and tumor-activated therapeutics and biologics; Pharmaceutical research and development services relating to the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases using proprietary conditional antibody technology for the design, development, testing, and validation of pharmaceutical substances and drug candidates; conducting clinical and pre-clinical research being scientific research in the nature of conducting clinical trials for others relating to pharmaceuticals and biotechnology in the fields of immunotherapy, immune-modulating therapy, oncology, immunology, autoimmune, metabolic, and inflammatory diseases; pharmaceutical research and development relating to the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; providing scientific information in the field of pharmaceutical, biotechnological, and clinical research